Literature DB >> 11238840

Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

M J Song1, H J Brown, T T Wu, R Sun.   

Abstract

Human herpesvirus 8 (HHV-8) (also known as Kaposi's sarcoma-associated herpesvirus) encodes a novel noncoding polyadenylated nuclear (PAN) RNA (also known as T1.1 or nut-1) during the early phase of lytic replication. PAN RNA is the most abundant transcript of HHV-8, comprising 80% of total poly(A)-selected transcripts in HHV-8-infected cells during lytic replication. We directly measured the abundance of PAN RNA by visualizing 1.1- to 1.2- kb PAN RNA in an ethidium bromide-stained gel from poly(A)-selected RNA. We further pursued the mechanisms by which PAN RNA expression is induced to such high levels. rta, an immediate-early gene of HHV-8, is a transactivator that is sufficient and necessary to activate lytic gene expression in latently infected cells. Ectopic expression of Rta was previously shown to induce PAN RNA expression from the endogenous viral genome and activate the PAN promoter in a reporter system. Here, we have identified the Rta-responsive element (RRE) in the PAN promoter. Deletion analysis revealed that the RRE is present in a region between nucleotides -69 and -38 of the PAN promoter. A promoter construct containing the 69 nucleotides upstream of the transcription start site of the PAN promoter was activated by Rta in the absence or presence of the HHV-8 genome. Rta activated the PAN promoter up to 7,000-fold in 293T cells and 2,000-fold in B cells. Electrophoretic mobility shift assays demonstrated that Rta formed a highly stable complex with the RRE of the PAN promoter. Our study suggests that Rta can induce PAN RNA expression by direct binding of Rta to the RRE of the PAN promoter. This study has highlighted an important mechanism controlling PAN RNA expression and also provides a model system for investigating how Rta transactivates gene expression during lytic replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238840      PMCID: PMC114107          DOI: 10.1128/JVI.75.7.3129-3140.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases.

Authors:  A Whitehouse; I M Carr; J C Griffiths; D M Meredith
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Baculoviral transfer vectors for expression of FLAG fusion proteins in insect cells.

Authors:  S S Koh; C J Hengartner; R A Young
Journal:  Biotechniques       Date:  1997-10       Impact factor: 1.993

3.  Identification of a cis-acting element within the herpesvirus saimiri ORF 6 promoter that is responsive to the HVS.R transactivator.

Authors:  A Whitehouse; A J Stevenson; M Cooper; D M Meredith
Journal:  J Gen Virol       Date:  1997-06       Impact factor: 3.891

4.  A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins.

Authors:  J Nicholas; V Ruvolo; J Zong; D Ciufo; H G Guo; M S Reitz; G S Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.

Authors:  J A Reed; R G Nador; D Spaulding; Y Tani; E Cesarman; D M Knowles
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

6.  Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).

Authors:  R Sarid; O Flore; R A Bohenzky; Y Chang; P S Moore
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Authors:  W Zhong; D Ganem
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.

Authors:  D M Lukac; J R Kirshner; D Ganem
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.

Authors:  D M Lukac; R Renne; J R Kirshner; D Ganem
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

View more
  95 in total

1.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Authors:  Yuying Liang; Jean Chang; Stephen J Lynch; David M Lukac; Don Ganem
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

2.  Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.

Authors:  Yan Wang; Hong Li; Man Yee Chan; Fan Xiu Zhu; David M Lukac; Yan Yuan
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Viral factors reveal a role for REF/Aly in nuclear RNA stability.

Authors:  Sarah H Stubbs; Olga V Hunter; Ashley Hoover; Nicholas K Conrad
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

4.  A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts.

Authors:  Nicholas K Conrad; Joan A Steitz
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

5.  Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA.

Authors:  Pey-Jium Chang; Duane Shedd; George Miller
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhilong Yang; Charles Wood
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Transcriptional control by the R-transactivator protein of alcelaphine herpesvirus-1.

Authors:  F M Frame; R G Dalziel
Journal:  Vet Res Commun       Date:  2007-11-20       Impact factor: 2.459

8.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

9.  Murine Gammaherpesvirus 68 ORF48 Is an RTA-Responsive Gene Product and Functions in both Viral Lytic Replication and Latency during In Vivo Infection.

Authors:  Jing Qi; Chuanhui Han; Danyang Gong; Ping Liu; Sheng Zhou; Hongyu Deng
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes.

Authors:  Linda M Persson; Angus C Wilson
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.